West Pharmaceutical Services, Inc.
WSTMedical Instruments & Supplies
$416.67+3.23%As of Oct 29vs prior close
- Market cap
- $29.3B
- P/E (TTM)
- 46.5×
- P/E (FY1)
- 46.5×
- From 52W high
- 0.00%
- EPS (LTM)
- $8.91
- Revenue (LTM)
- $3.4B
- Net margin
- 18.81%
- Dividend yield
- 0.21%
Nomior Score
66
Fortified DefenderTop 16% of the scored universe
Growth45
Quality71
Value38
Momentum76
Resilience69
Growth
+8.23%revenue a year over 9 fiscal years
FY16 $1.5BLTM $3.4B
Connections
Revenue to profitQ3 FY26
24% of revenue became net profit, up 7 pts on a year.
Latest results
- Revenue
- $874.5 million
- Diluted EPS
- $3.02
- Revenue outlook
- $3.41 billion to $3.42 billion
- EPS outlook
- $9.38 to $9.48
Net sales and profit rose strongly in the quarter, led by the High-Value Product Components business and operating margin expansion. Earnings per share also grew sharply, aided by a gain on an divestiture of a delivery device line. Management raised its full-year net sales and adjusted diluted EPS guidance.
Who owns it
6funds, 2 tracked portfolios